The “Comprehensive Biomarker Center (cbc)“, dedicates its research activities and its range of services to the identification, validation, analysis and interpretation of nucleic acid-based biomarkers.
The company’s particular competences focus on the identification of biomarker signatures from body fluids, comprehensive high-level bioinformatic analyses, and the development of proprietary biomarker signatures.
In these activities, the company relies on its experience from a multitude of studies involving thousands of clinical samples. The company has primarily distinguished itself with the development and patenting of blood-derived microRNA profiles.
As a center of excellence for genomic biomarkers, the CBC serves clients from academic clinical research as well as the pharmaceutical and biotech industry in their biomarker discovery and companion diagnostic development efforts.